NCT01946009View on ClinicalTrials.gov

A Prospective, With One Site, Open-label Not Controled Trial, for the Observation of Treatment With CIDOFOVIR 1%, 3 Nights Per Week, During 4 Weeks, of Anal Intraepithelial Neoplasia, High Level, in HIV+ Patients

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
HIV
Interventions
DRUG

Cidofovir 1% cream's basis, 2gr, three times per week, during 4 weeks.

Trial Locations (1)

Unknown

Hospital Universitario La Paz, Madrid

All Listed Sponsors
lead

Fundacion SEIMC-GESIDA

OTHER

NCT01946009 - A Prospective, With One Site, Open-label Not Controled Trial, for the Observation of Treatment With CIDOFOVIR 1%, 3 Nights Per Week, During 4 Weeks, of Anal Intraepithelial Neoplasia, High Level, in HIV+ Patients | Biotech Hunter | Biotech Hunter